Chronic Cough (CC) affects 8-10% of the US population, limiting persons’ employment and isolating them from others due to their constant uncontrollable coughing. Medications are often ineffective, costly, and unsafe due to sedating side effects. We will significantly improve lives and build a valuable business in Virginia by marketing the first effective long term safe treatment with our patented wearable Chronic Cough Controller “CCC”. The CCC vibrates mechanoreceptors in the trachea reducing patients’ constant urge-to-cough, training long term cough control, and eliminating the need for medications.
Contact Us
Have a question or want to subscribe to updates?
Advisor Team
Erin Kamarunas, Associate Professor, Speech Pathology
Christy Ludlow, Professor (Retired), Speech Pathology
This innovation is supported by James Madison Innovations, Inc. (JMI)
James Madison Innovations, Inc. (JMI), is a JMU 501(c)(3) non-profit corporation for intellectual property management and licensing organization, the two entities connect researchers, entrepreneurs, and professionals in industry and support services to bolster the entrepreneurial infrastructure and promote innovation in the Valley. Learn More